-
Hutchison Medicine announces that Sofatinib is approved for the treatment of advanced pancreatic neuroendocrine tumors
Time of Update: 2021-08-11
Hutchison Pharmaceuticals (Nasdaq/London Stock Exchange: HCM) today announced that Sofatinib has been officially approved by the China National Medical Products Administration ("SFDA") for the treatment of advanced pancreatic neuroendocrine tumors (pNETs) .
The median PFS for patients in the sofatinib treatment group was 10.
-
Baiyunshan: Cefuroxime sodium for injection passed the consistency evaluation of generic drugs
Time of Update: 2021-08-11
On June 22, Baiyunshan announced that its subsidiary Tianxin Pharmaceutical's cefuroxime sodium for injection has passed the consistency evaluation of generic drugs .
According to public information, the domestic manufacturers of cefuroxime sodium for injection that have passed or deemed to have passed the consistency evaluation include Zhejiang Huidisen Pharmaceutical Co.
-
Luoxin Pharmaceutical Introduces Tigolasan Injection
Time of Update: 2021-08-11
N Corporation (formerly CJHealthCare Corporation) signed a "License Agreement" on June 23, 2021, and reached an agreement on the introduction of ticolasan injection products According to the agreement, Shandong Luoxin will obtain the exclusive right to develop, produce and commercialize the product in China .
After the signing of the agreement, Shandong Luoxin will pay HK inno.
-
Pradaxa, the first oral blood thinning drug for children, receives FDA approval
Time of Update: 2021-08-11
In addition, Pradaxa oral pills are also approved to prevent recurrence of thrombosis in children from 3 months to 12 years old, who have received complete treatment after their first venous thromboembolism .
-
Which pharmaceutical companies are making friends of time?
Time of Update: 2021-08-11
WuXi AppTec,Source: Company Annual ReportHengrui Pharmaceuticals, despite the fact that Hengrui’s sales staff account for the largest proportion, but Hengrui ranks first in R&D expenses.
-
Aiming at "gradual freezing"!
Time of Update: 2021-08-11
Article source: Pharmaceutical GuanlanRecently, Magpie Medicine's Class 1 new drug nitroxazine for the treatment of amyotrophic lateral sclerosis (ALS) has obtained the implied approval of the US FDA clinical trial, and a phase 1 clinical bridging trial will be launched in the United States .
-
Eight departments: Achieve a stable independent supply of commonly used medical isotopes by 2025
Time of Update: 2021-08-11
Medical Network News, June 25, June 24, the National Atomic Energy Agency, the Ministry of Science and Technology, the Ministry of Public Security, the Ministry of Ecology and Environment, the Minist
-
The National Medical Insurance Negotiations List of Drug Provision Institutions (Second Batch) Released!
Time of Update: 2021-08-11
Compared with the list of negotiated drug allocation institutions released at the end of April 2021 (the first batch), the number of drugs involved this time has increased from 19 to 92, all of which are newly included in the national medical insurance list in the 2020 negotiation .
-
How do tigers and hungry wolves wait for Chinese generic drug companies to get rid of the struggle between trapped animals?
Time of Update: 2021-08-11
Although Teva has more than 1,800 generic drug products, in China, this century-old pharmaceutical company chose to enter the Chinese market with special drugs as an incision .
-
Hengrui Medicine: SHR7280 tablets for the treatment of prostate cancer approved for clinical trials
Time of Update: 2021-08-11
After review, the SHR7280 tablets accepted on April 16, 2021 meet the relevant requirements of drug registration, and the drug is approved for clinical trials in prostate cancer patients .
-
2020 Annual Drug Evaluation Report
Time of Update: 2021-08-11
Announcement) and related supporting documents of the "Administrative Measures for Drug Registration", the Center for Drug Evaluation has completed the review and approval of various types of registration applications for Chinese medicines (including ethnic medicines, the same below), chemical medicines, and biological products, a total of 11,582 (including 4 device combination products) , Counted by the acceptance number, the same below), an increase of 32.
-
Hengrui Medicine's bevacizumab biosimilar drug approved
Time of Update: 2021-08-11
On June 22, the official website of China National Medical Products Administration showed that Hengrui Medicine's bevacizumab biosimilar was approved in China for metastatic colorectal cancer and advanced, metastatic or recurrent non-small cell lung cancer Indications .
-
Roche IL-6 receptor inhibitor receives FDA emergency use authorization to treat severe COVID-19 hospitalized patients
Time of Update: 2021-08-11
On June 25, 2021, Roche announced that the US FDA granted its intravenous IL-6 receptor inhibitor Actemra/RoActemra (tocilizumab) emergency use authorization (EUA) for the treatment of adult patients hospitalized with COVID-19 And pediatric patients two years and older .
-
New requirements for continuing education of licensed pharmacists are coming
Time of Update: 2021-08-11
At the same time, pharmacy professional and technical personnel receive continuing education and obtain the required credits as one of the necessary conditions for annual assessment and term assessment, professional and technical post promotion, appointment and practice re-registration .
-
Cansino: Group A and C meningococcal polysaccharide conjugate vaccine obtained drug registration certificate
Time of Update: 2021-08-11
Meningococcal disease is a serious infectious disease mainly caused by Neisseria meningitidis, with the highest incidence among infants and young children under 12 months of age .
The incidence of meningococcal disease is highest among infants and young children under 12 months of age.
-
Pien Tze Huang, which weighs only 3 grams per grain, sells for as high as 590 yuan. Who is behind the scenes?
Time of Update: 2021-08-11
However, a reporter from the Beijing Youth Daily inquired into the “ OTC Traditional Chinese Medicine Instruction Template” database of the National Food and Drug Administration and found that the function of the “Pien Tze Huang” instruction is “clearing heat and detoxification, cooling blood and removing blood stasis, reducing swelling and relieving pain .
-
China Resources Sanjiu Tracing Mitoxantrone Hydrochloride Injection Obtained Drug Registration Certificate
Time of Update: 2021-08-11
, has recently received a tracer-use mitoxantrone hydrochloride injection (trade name: Futasu) issued by the State Food and Drug Administration.
Mitoxantrone hydrochloride injection for tracer belongs to two new drugs.
-
11 net profits doubled!
Time of Update: 2021-08-11
6 billion yuan, and 11 companies including Kelun Pharmaceutical, Harbin Sanlian, Xinbang Pharmaceutical, and Zuoli Pharmaceutical were expected to double their net profits.
6 billion yuan, and 11 companies including Kelun Pharmaceutical, Harbin Sanlian, Xinbang Pharmaceutical, and Zuoli Pharmaceutical were expected to double their net profits.
-
The fifth batch of national organization of centralized drug procurement announced the results of the proposed selection: the average price of the proposed selection of drugs was reduced by 56%
Time of Update: 2021-08-11
It is reported that since the establishment of the National Medical Insurance Bureau, it has carried out 5 batches of centralized drug purchases, covering 218 varieties, and involving a market capacity of 220 billion yuan .
-
Shanghai and Beijing become the most competitive pharmaceutical industry centers in the Asia-Pacific region
Time of Update: 2021-08-11
In the Beijing market, CB Richard Ellis found that active investments in the life sciences industry have brought demands for corporate tenants to upgrade office space, and business parks are preferred for the expansion of local pharmaceutical companies .
